What changed today in Aesthetics & Longevity: 1 new study
Every new official record on the Aesthetics, Regenerative & Longevity Medicine desk since this morning, each linked to its primary source.
Automated from official records2 sources1 min read
Hormonal health & BHRT
Hormone therapy, including compounded bioidentical hormones, testosterone therapy and menopause care.
Emerging
- Editorial attention
- Emerging
- Tracked this week
- 3
- Sources this week
- 2
- Last activity
- 4 days ago
Signal strength reflects editorial attention across tracked sources — not medical certainty or strength of evidence.
- Pending editorial review
A system check is an automated check of the official sources, not a human review. An editorial review is recorded only when one of our editors has reviewed the page.
Hormonal health & BHRT at a glance
- About this topic
- Hormone therapy, including compounded bioidentical hormones, testosterone therapy and menopause care.
- Current status
- No editor-reviewed status summary yet. The official records below update automatically.
- Last updated
- Primary sources
- Latest official record: Nutrition Care Strategies at the Intersection of Menopause and Obesity Pharmacotherapy (opens the source in a new tab) (The Journal of nutrition, Nov 9, 2026)
- Key facts from tracked records
- 4 NPHLA briefings on this topic
What’s the latest on Hormonal health & BHRT?
4 totalWhat changed today in Aesthetics & Longevity: 1 trial update, 1 FDA announcement
Every new official record on the Aesthetics, Regenerative & Longevity Medicine desk since this morning, each linked to its primary source.
Automated from official records5 sources1 min read
What changed today in Metabolic: 2 trial updates, 1 new study
Every new official record on the Metabolic & Weight-Loss Intelligence desk since this morning, each linked to its primary source.
Automated from official records5 sources1 min read
What changed today in Metabolic: 4 new studies, 3 trial updates
Every new official record on the Metabolic & Weight-Loss Intelligence desk since this morning, each linked to its primary source.
Automated from official records9 sources1 min read
What do the official records show?
Primary sources and peer-reviewed research- Nutrition Care Strategies at the Intersection of Menopause and Obesity Pharmacotherapy (opens the source in a new tab)
- FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women (opens the source in a new tab)
Today, the U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week.
- Weight Regain After Incretin Treatment: The Lean Mass Deficit Hypothesis and a Role for Testosterone Combination Therapy in Men (opens the source in a new tab)
- GLP-1 receptor agonists in perimenopause and early postmenopause: clinical role, cardiometabolic benefits and knowledge gaps (opens the source in a new tab)
- Incretin-based therapies in peri- and postmenopausal women with obesity: an expert position statement from the Spanish Menopause Society (opens the source in a new tab)
- Class II recall: Testosterone Topical Cream 4% (opens the source in a new tab)
Reason: Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.. Recalling firm: MPRX, Inc. dba Medical Park Pharmacy (TX). Status: Terminated.
Industry coverage
Headlines link to the original publication- Menopause and Aesthetics: What Medical Spas Need to Know About Skin Changes (opens the source in a new tab)
- Rheumatoid Arthritis Does Not Improve the Menopause Experience (opens the source in a new tab)
- More Women on Testosterone; Hormone Patch Updates; Drug-Induced Bone Loss (opens the source in a new tab)